Skip to main content

Provider

By Emily Olsen | 01:07 pm | July 28, 2022
A study published in JAMA Network Open found low health literacy and a higher area deprivation index were associated with more audio-only telehealth visits.
By Adam Ang | 01:14 am | July 28, 2022
It follows the clearance for connecting Hailie with AstraZeneca's Symbicort inhaler.
HIMSS22 Europe
By HIMSS TV | 07:00 am | July 27, 2022
The effort to strengthen the digital health workforce needs cooperation and streamlining, says Georgi Chaltikyan, MD, head of digital health and professor at Deggendorf Institute of Technology.
HIMSS22
By HIMSS TV | 07:00 am | July 26, 2022
Availity's VP of product management Mark Martin explains how the company seeks to give payers and providers a streamlined process for approvals, referrals and claims management via AI and machine learning.                                              
SPONSORED HIMSS22 Europe
By ServiceNow | HIMSS TV | 05:10 pm | July 25, 2022
Care delivery can't only happen at the hospital, according to Mike Luessi, global head of healthcare and life sciences at ServiceNow. The home must be a setting for care delivery beyond the hospital.
HIMSS22
By HIMSS TV | 07:00 am | July 25, 2022
Precision medicine is entering the mainstream, from genetic insights informing a range of specialties to primary care using pharmacogenomics, according to Dr. Joel Diamond of 2bPrecise.
By Emily Olsen | 01:08 pm | July 22, 2022
The latest clearance is for an algorithm that characterizes how much atrial fibrillation a patient is experiencing over time.
By Emily Olsen | 11:54 am | July 21, 2022
The partnership will allow Withings' connected scales, blood pressure monitors and sleep-tracking mats to integrate with Medable's trial platform.
HIMSS22
By HIMSS TV | 07:00 am | July 21, 2022
Smile, a FHIR-based enterprise data platform, helps manage data from a variety of sources for payers, providers and researchers, according to Duncan Weatherston, CEO of Smile CDR.
By Adam Ang | 02:14 am | July 21, 2022
The VR app has been shown to reduce 75% of phobia symptoms after six weeks of treatment.